PER 1.27% 7.8¢ percheron therapeutics limited

Combo Data, page-45

  1. 76 Posts.
    lightbulb Created with Sketch. 17
    thanks Itsa - I wasn't intending to have a go at you. I found your post -

    Capricor: their 12 month data on PUL2 (+1.8) is no better than their 6 month data.Atl1102 had a +2.9 vs the natural history control at 6 months which presented at the last WMS. They have no myoset or MRI data.There other observations aren’t worth much. They have a safety issue with the need to pre-dose with an antihistamine.They are requiring a partner to fund to their pivotal study in DMD, focussing their resources on Covid.Sankaido: I hope that helps .. No comparison to AnpOriginally posted by sankaido: ↑

    The big things that have changed are that they have got their partner and their funding (and trials underway I think)
    You commented that they have a safety issue with the need to pre-dose with an antihistamine - try as I may I have not got a useful understanding of the science behind either their product and ours - Would you be able to get an opinion that aspect from one of your contacts ?



    Perhaps Wayne

    .

 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
7.8¢
Change
-0.001(1.27%)
Mkt cap ! $80.86M
Open High Low Value Volume
8.0¢ 8.0¢ 7.7¢ $374.4K 4.803M

Buyers (Bids)

No. Vol. Price($)
3 308385 7.8¢
 

Sellers (Offers)

Price($) Vol. No.
8.0¢ 818650 4
View Market Depth
Last trade - 16.10pm 04/11/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.